Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
9
×
Tags
national blog main
9
×
life sciences
boston blog main
boston top stories
fda
national top stories
san francisco blog main
wisconsin blog main
wisconsin top stories
biotech
detroit blog main
detroit top stories
medicare
national
new york blog main
new york top stories
san francisco top stories
seattle blog main
boulder/denver blog main
boulder/denver top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle top stories
texas blog main
texas top stories
bristol-myers squibb
drug price
healthcare
jim greenwood
merck
regeneron pharmaceuticals
startups
vc
abeona therapeutics
affordable care act
agios pharmaceuticals
What
industry
9
×
healthcare
bio
health
people
policy
roundup
scalps
u.s
american
based
best
continue
crash
debate
kind
nash
pharmaceutical
politicians
pressure
price
trump’s
according
account
administration
adversity
aids
andreessen
angry
answer
anti
approach
arrival
baby
beats
benefited
biopharma
biotech
boomers
border
Language
unset
Current search:
industry
×
photo
×
" national blog main "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
MedHealth Summit Brings Together Cross-Border Innovators and Experts
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Andreessen Leads $300M Bet on Devoted Health’s Senior Care Approach
@xconomy.com
5 years ago
Tcare’s Software Aids People Who Live with, and Care for, Loved Ones
@xconomy.com
6 years ago
Exact Sciences Beats Quarterly Forecasts, Sending Its Stock Price Up